糖尿病足部并发症

Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3273.全文  摘要

National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. Oct 2019 [internet publication].全文

Boulton AJ, Armstrong DG, Kirsner RS, et al; American Diabetes Association. Diagnosis and management of diabetic foot complications. 2018 [internet publication].全文

Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan;59(1):220-34.全文  摘要

1. van Netten JJ, Bus SA, Apelqvist J, et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3268.全文  摘要

2. Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3266.全文  摘要

3. Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3273.全文  摘要

4. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. Oct 2019 [internet publication].全文

5. Diabetes UK. Diabetes prevalence 2019 [internet publication].全文

6. Centers for Disease Control and Prevention. US diabetes surveillance system: diagnosed diabetes. 2017 [internet publication].全文

7. Centers for Disease Control and Prevention. National diabetes statistics report, 2017: estimates of diabetes and its burden in the United States. 2017 [internet publication].全文

8. Barshes NR, Sigireddi M, Wrobel JS, et al. The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle. 2013 Oct 10;4:21847.全文  摘要

9. Boyko EJ, Ahroni JH, Cohen V, et al. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006 Jun;29(6):1202-7.全文  摘要

10. NHS Digital. National diabetes foot care audit (NDFA) sixth national report: England and Wales July 2014-March 2021. May 2022 [internet publication].全文

11. Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008 Aug;31(8):1679-85.全文  摘要

12. Prompers L, Huijberts M, Apelqvist J, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med. 2008 Jun;25(6):700-7. 摘要

13. Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006 Jun;29(6):1288-93.全文  摘要

14. LoGerfo FW, Coffman JD. Current concepts: vascular and microvascular disease of the foot in diabetes - implications for foot care. N Engl J Med. 1984 Dec 20;311(25):1615-9. 摘要

15. Armstrong DG, Boulton AJ, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017 Jun 15;376(24):2367-75. 摘要

16. Lavery LA, Peters EJ, Williams JR, et al. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2008 Jan;31(1):154-6.全文  摘要

17. Crawford F, Cezard G, Chappell FM, et al. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess. 2015 Jul;19(57):1-210.全文  摘要

18. Bus SA, Lavery LA, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3269.全文  摘要

19. American Diabetes Association. Standards of care in diabetes - 2023. Diabetes Care. 2023 Jan;46(suppl 1):S1-291.全文

20. Boyko EJ, Zelnick LR, Braffett BH, et al. Risk of foot ulcer and lower-extremity amputation among participants in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2022 Feb 1;45(2):357-64.全文  摘要

21. Boulton AJ, Armstrong DG, Kirsner RS, et al; American Diabetes Association. Diagnosis and management of diabetic foot complications. 2018 [internet publication].全文

22. Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280.全文  摘要

23. National Institute for Health and Care Excellence. Peripheral arterial disease: diagnosis and management. December 2020 [internet publication].全文

24. Butalia S, Palda VA, Sargeant RJ, et al. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008 Feb 20;299(7):806-13. 摘要

25. Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3276.全文  摘要

26. Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Apr 2;127(13):1425-43.全文  摘要

27. Ince P, Abbas ZG, Lutale JK, et al. Use of the SINBAD classification system and score in comparing outcome of foot ulcer management on three continents. Diabetes Care. 2008 May;31(5):964-7.全文  摘要

28. NHS Digital. National diabetes foot care audit. [internet publication].全文

29. Lavery LA, Armstrong DG, Murdoch DP, et al. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007 Feb 15;44(4):562-5.全文  摘要

30. Bravo-Molina A, Linares-Palomino JP, Vera-Arroyo B, et al. Inter-observer agreement of the Wagner, University of Texas and PEDIS classification systems for the diabetic foot syndrome. Foot Ankle Surg. 2018 Feb;24(1):60-4.全文  摘要

31. Monteiro-Soares M, Martins-Mendes D, Vaz-Carneiro A, et al. Lower-limb amputation following foot ulcers in patients with diabetes: classification systems, external validation and comparative analysis. Diabetes Metab Res Rev. 2015 Jul;31(5):515-29. 摘要

32. Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014 Jan;59(1):220-34.全文  摘要

33. Zhan LX, Branco BC, Armstrong DG, et al. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg. 2015 Apr;61(4):939-44.全文  摘要

34. Rayman G, Vas P, Dhatariya K, et al. Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3283.全文  摘要

35. National Institute for Health and Care Excellence. UrgoStart for treating diabetic foot ulcers and leg ulcers. Apr 2023 [internet publication].全文

36. Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, et al. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186-96. 摘要

37. Bus SA, Armstrong DG, Gooday C, et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3274.全文  摘要

38. US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. December 2018 [internet publication].全文

39. European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication].全文

40. Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. March 2019 [internet publication].全文

41. US Food and Drug Administration. FDA drug safety communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication].全文

42. US Food and Drug Administration. FDA drug safety communication: FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. July 2018 [internet publication].全文

43. Barshes NR, Belkin M; MOVIE Study Collaborators. A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg. 2011 Oct;213(4):552-66. 摘要

44. Williams DT, Majeed MU, Shingler G, et al. A diabetic foot service established by a department of vascular surgery: an observational study. Ann Vasc Surg. 2012 Jul;26(5):700-6. 摘要

45. Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the Limb Preservation Service model. Diabetes Care. 2005 Feb;28(2):248-53.全文  摘要

46. Canavan RJ, Unwin NC, Kelly WF, et al. Diabetes- and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care: continuous longitudinal monitoring using a standard method. Diabetes Care. 2008 Mar;31(3):459-63.全文  摘要

47. Armstrong DG, Bharara M, White M, et al. The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. Diabetes Metab Res Rev. 2012 Sep;28(6):514-8. 摘要

48. Mills JL, Beckett WC, Taylor SM. The diabetic foot: consequences of delayed treatment and referral. South Med J. 1991 Aug;84(8):970-4. 摘要

49. Hughes OB, Rakosi A, Macquhae F, et al. A review of cellular and acellular matrix products: indications, techniques, and outcomes. Plast Reconstr Surg. 2016 Sep;138(3 suppl):138-47S. 摘要

50. Martí-Carvajal AJ, Gluud C, Nicola S, et al. Growth factors for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2015 Oct 28;(10):CD008548.全文  摘要

51. Frykberg RG, Franks PJ, Edmonds M, et al. A multinational, multicenter, randomized, double-blinded, placebo-controlled trial to evaluate the efficacy of cyclical topical wound oxygen therapy (TWO2) in the treatment of chronic diabetic foot ulcers: the TWO2 study. Diabetes Care. 2020 Mar;43(3):616-624..全文  摘要

52. Health Quality Ontario. Hyperbaric oxygen therapy for the treatment of diabetic foot ulcers: a health technology assessment. Ont Health Technol Assess Ser. 2017 May 12;17(5):1-142.全文  摘要

53. Wenhui L, Changgeng F, Lei X, et al. Hyperbaric oxygen therapy for chronic diabetic foot ulcers: an overview of systematic reviews. Diabetes Res Clin Pract. 2021 Jun;176:108862. 摘要

54. Ramanujam CL, Zgonis T. Use of local flaps for soft-tissue closure in diabetic foot wounds: a systematic review. Foot Ankle Spec. 2019 Jun;12(3):286-93. 摘要

55. Game F, Jeffcoate W, Tarnow L, et al. LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial. Lancet Diabetes Endocrinol. 2018 Sep 19;6(11):870-8. 摘要

56. National Institute for Health and Care Excellence. 3C Patch for treating diabetic foot ulcers. Mar 2022 [internet publication].全文

57. Armstrong DG, Swerdlow MA, Armstrong AA, et al. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020 Mar 24;13(1):16.全文  摘要

58. Lam K, van Asten SA, Nguyen T, et al. Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review. Clin Infect Dis. 2016 Oct 1;63(7):944-8.全文  摘要

59. Tone A, Nguyen S, Devemy F, et al. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care. 2015 Feb;38(2):302-7.全文  摘要

60. Gariani K, Pham TT, Kressmann B, et al. Three weeks versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, noninferiority pilot trial. Clin Infect Dis. 2021 Oct 5;73(7):e1539-45. 摘要

61. Baglioni P, Malik M, Okosieme OE. Acute Charcot foot. BMJ. 2012 Mar 14;344:e1397. 摘要

62. Game FL, Catlow R, Jones GR, et al. Audit of acute Charcot's disease in the UK: the CDUK study. Diabetologia. 2012 Jan;55(1):32-5.全文  摘要

63. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011 Sep;34(9):2123-9.全文  摘要

64. Berceli SA, Hevelone ND, Lipsitz SR, et al. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg. 2007 Dec;46(6):1173-9.全文  摘要

65. Miller JD, Salloum M, Button A, et al. How can I maintain my patient with diabetes and history of foot ulcer in remission? Int J Low Extrem Wounds. 2014 Dec;13(4):371-7. 摘要

66. Armstrong DG, Mills JL. Toward a change in syntax in diabetic foot care: prevention equals remission. J Am Podiatr Med Assoc. 2013 Mar-Apr;103(2):161-2. 摘要